1250745

Oxygen Development, L.L.C. — FEI 3009461317

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 11, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Palm Springs, FL (United States)

Citations

IDCFRDescription
178721 CFR 211.80(a)Procedures To Be in Writing
180221 CFR 211.84(b)Representative Samples
202721 CFR 211.192Investigations of discrepancies, failures